Financhill
Back

Intellia Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Intellia Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 8.13 Buy
20-day SMA: 8.23 Buy
50-day SMA: 8.17 Buy
200-day SMA: 14.24 Sell
8-day EMA: 8.2 Buy
20-day EMA: 8.12 Buy
50-day EMA: 8.5 Buy
200-day EMA: 13.7 Sell

Intellia Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 53.64 Buy
Chaikin Money Flow: 2308661 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.5 - 8.58) Buy
Bollinger Bands (100): (7.82 - 11.14) Sell

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Intellia Therapeutics Stock

Is Intellia Therapeutics Stock a Buy?

NTLA Technical Analysis vs Fundamental Analysis

Sell
36
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy or a Sell?

Intellia Therapeutics Stock Info

Market Cap:
880.5M
Price in USD:
8.50
Share Volume:
2.5M

Intellia Therapeutics 52-Week Range

52-Week High:
28.18
52-Week Low:
5.90
Sell
36
Intellia Therapeutics (NTLA) is a Sell

Intellia Therapeutics Share Price Forecast

Is Intellia Therapeutics Stock a Buy?

Fundamental Analysis of Intellia Therapeutics

Is Intellia Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.08 per share, and an increase next year of $0.23 per share.

Technical Analysis of Intellia Therapeutics

Should I short Intellia Therapeutics stock?

* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.